Aminolevulinic Acid
Back to searchMolecule Structure
Scientific Name
Aminolevulinic Acid
Description of the Drug
Aminolevulinic acid is a porphyrin precursor used to treat actinic keratosis of the face, scalp, and upper extremities, as well as to visualize a glioma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00855
http://www.drugbank.ca/drugs/DB00855
Brand Name(s)
Not Available
Company Owner(s)
Nx Development Corp, Biofrontera Bioscience Gmbh, Dusa Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8243 | ||||||||
| PharmGKB | PA10015 | ||||||||
| Human Metabolome Database | HMDB0001149 | ||||||||
| DrugBank | DB00855 | ||||||||
| PubChem: Thomson Pharma | 15170674 | ||||||||
| PubChem | 7048523 | 137 | |||||||
| Mcule | MCULE-8676354165 | ||||||||
| NMRShiftDB | 60020706 | ||||||||
| LINCS | LSM-5677 | ||||||||
| Nikkaji | J38.537I | ||||||||
| PDBe | FVT | ||||||||
| BindingDB | 50240386 | ||||||||
| EPA CompTox Dashboard | DTXSID8048490 | ||||||||
| LipidMaps | LMFA01100055 | ||||||||
| DrugCentral | 166 | ||||||||
| Metabolights | MTBLC17549 | MTBLC356416 | |||||||
| Brenda | 50690 | 233904 | 207706 | 207707 | 1393 | 166151 | 4489 | 101752 | 135696 |
| Rhea | 356416 | ||||||||
| ChemicalBook | CB5265495 | ||||||||
| Guide to Pharmacology | 4784 | ||||||||
| rxnorm | AMINOLEVULINIC ACID HYDROCHLORIDE | AMINOLEVULINATE | AMELUZ | LEVULAN | AMINOLEVULINIC ACID | ||||
| KEGG Ligand | C00430 | ||||||||
| ChEBI | 356416 | 17549 | |||||||
| ZINC | ZINC000003782550 |
